Search

everythinglearnresearchcommunity

for

Search:↓

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

High doses of norethindrone acetate in rats caused various organ changes but didn't significantly increase tumor rates.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Mitochondria change shape to meet energy needs during cell movement.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Pregnancy can cause normal skin changes, including darkening of certain areas, nail changes, vascular changes, and breast changes like stretch marks.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

The woman has a skin condition involving nodules, scars, and hair loss.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Sonidegib and vismodegib have different side effects and reporting patterns.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Tailored scar treatments are needed for different body areas to improve appearance and function.

Children with Parry Romberg Syndrome had successful facial fat-grafting surgeries after disease stabilization with no complications.

Active vitamin D3 might protect hair follicles from radiation damage.

Menopause affects hair and skin; more research needed for treatment.

The document concludes that stem cells and their environments are crucial for skin and hair health and have potential for medical treatments.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.